ESM-1 has been recently studied as a biomarker candidate for endothelial dysfunction and inflammation because increased ESM-1 levels in tissue or serum reflect endothelial activation and neoangiogenesis, which are marked pathophysiological changes involved in inflammation [8,9,10]. The gene discussed is ESM1; the disease is endothelial dysfunction.